IN8bio, Inc.INABNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank43
Studio
Year-over-Year Change

Return on equity

Latest
-70.54%
↓ 168% vs avg
Percentile
P43
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
103.42%
Historical baseline
PeriodValueYoY Change
2025-70.54%+66.4%
2024-210.23%-74.7%
2023-120.33%+4.1%
2022-125.47%-226.9%
2021-38.38%+17.8%
2020-46.71%-103.1%
20191483.82%+3413.4%
2018-44.78%-